ALEC
Price
$3.17
Change
-$0.16 (-4.82%)
Updated
Oct 6, 12:14 PM (EDT)
Capitalization
336.02M
36 days until earnings call
CTXR
Price
$1.34
Change
-$0.03 (-2.19%)
Updated
Oct 6, 02:41 PM (EDT)
Capitalization
23.31M
Interact to see
Advertisement

ALEC vs CTXR

Header iconALEC vs CTXR Comparison
Open Charts ALEC vs CTXRBanner chart's image
Alector
Price$3.17
Change-$0.16 (-4.82%)
Volume$200
Capitalization336.02M
Citius Pharmaceuticals
Price$1.34
Change-$0.03 (-2.19%)
Volume$300
Capitalization23.31M
ALEC vs CTXR Comparison Chart in %
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALEC vs. CTXR commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALEC is a Hold and CTXR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (ALEC: $3.32 vs. CTXR: $1.37)
Brand notoriety: ALEC and CTXR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALEC: 183% vs. CTXR: 104%
Market capitalization -- ALEC: $336.02M vs. CTXR: $23.31M
ALEC [@Biotechnology] is valued at $336.02M. CTXR’s [@Biotechnology] market capitalization is $23.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALEC’s FA Score shows that 0 FA rating(s) are green whileCTXR’s FA Score has 1 green FA rating(s).

  • ALEC’s FA Score: 0 green, 5 red.
  • CTXR’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALEC and CTXR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALEC’s TA Score shows that 4 TA indicator(s) are bullish while CTXR’s TA Score has 4 bullish TA indicator(s).

  • ALEC’s TA Score: 4 bullish, 5 bearish.
  • CTXR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ALEC and CTXR are a bad buy in the short-term.

Price Growth

ALEC (@Biotechnology) experienced а +7.10% price change this week, while CTXR (@Biotechnology) price change was +19.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.50%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +83.81%.

Reported Earning Dates

ALEC is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+5.50% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALEC($336M) has a higher market cap than CTXR($23.3M). ALEC YTD gains are higher at: 75.661 vs. CTXR (-65.750). CTXR has higher annual earnings (EBITDA): -43.9M vs. ALEC (-125.18M). ALEC has more cash in the bank: 307M vs. CTXR (6.09M). CTXR has less debt than ALEC: CTXR (1.88M) vs ALEC (39.5M). ALEC has higher revenues than CTXR: ALEC (81.1M) vs CTXR (0).
ALECCTXRALEC / CTXR
Capitalization336M23.3M1,442%
EBITDA-125.18M-43.9M285%
Gain YTD75.661-65.750-115%
P/E RatioN/AN/A-
Revenue81.1M0-
Total Cash307M6.09M5,042%
Total Debt39.5M1.88M2,099%
FUNDAMENTALS RATINGS
ALEC vs CTXR: Fundamental Ratings
ALEC
CTXR
OUTLOOK RATING
1..100
8220
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
8
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3664
P/E GROWTH RATING
1..100
94100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CTXR's Valuation (8) in the Pharmaceuticals Major industry is somewhat better than the same rating for ALEC (64) in the Biotechnology industry. This means that CTXR’s stock grew somewhat faster than ALEC’s over the last 12 months.

CTXR's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as ALEC (100) in the Biotechnology industry. This means that CTXR’s stock grew similarly to ALEC’s over the last 12 months.

CTXR's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as ALEC (100) in the Biotechnology industry. This means that CTXR’s stock grew similarly to ALEC’s over the last 12 months.

ALEC's Price Growth Rating (36) in the Biotechnology industry is in the same range as CTXR (64) in the Pharmaceuticals Major industry. This means that ALEC’s stock grew similarly to CTXR’s over the last 12 months.

ALEC's P/E Growth Rating (94) in the Biotechnology industry is in the same range as CTXR (100) in the Pharmaceuticals Major industry. This means that ALEC’s stock grew similarly to CTXR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALECCTXR
RSI
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
88%
Momentum
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 4 days ago
83%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 14 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 5 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSD4.370.30
+7.37%
Clearside Biomedical Inc
WRLD175.593.83
+2.23%
World Acceptance Corp
PJT179.512.24
+1.26%
PJT Partners
BPRN31.090.38
+1.24%
Princeton Bancorp
BKR48.500.10
+0.21%
Baker Hughes Company

CTXR and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTXR has been loosely correlated with KLTO. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CTXR jumps, then KLTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTXR
1D Price
Change %
CTXR100%
+3.01%
KLTO - CTXR
36%
Loosely correlated
+9.02%
HYPD - CTXR
33%
Poorly correlated
-6.42%
ALEC - CTXR
31%
Poorly correlated
+5.06%
VERA - CTXR
28%
Poorly correlated
+3.25%
TAOX - CTXR
28%
Poorly correlated
-9.59%
More